Cefepime ASTRA
Release Forms:
The composition of 1 solution for injection:
- active substance: cefepime; 1 bottle contains cefepime hydrochloride equivalent to cefepime 500 mg a6o 1000 mg
- excipients: L-arginine.
solution for injection 1000mg
Indications:
Adults.
Infections caused by microflora sensitive to cefepime:
- respiratory tract infections, including pneumonia;
- uncomplicated infections of the skin and subcutaneous tissue;
- complicated intra-abdominal infections (used in combination with metronidazole);
- uncomplicated and complicated urinary tract infections (including pyelonephritis);
- septicemia.
For empiric therapy in patients with neutropenic fever.
For the prevention of postoperative complications in the intra-abdominal xipyprïi.
Children.
- Pneumonia;
- urinary tract infections, including pyelonephritis;
- infections of the skin and subcutaneous tissue;
- bacterial meningitis.
For empiric therapy in patients with neutropenic fever.
Method of administration.
The solution for injection is intended for parenteral administration. The dose of the medicines is set by the doctor individually, depending on the severity of the disease, the patient’s age, the location of the infection, renal function.
The usual dosage for adults and children weighing more than 40 kg is 1 g intravenously a6o intramuscularly every 12 hours. The usual duration of treatment is 7-10 days. Severe infections may require longer treatment.